【7096】ステムセル研究所
再生医療を目的に、さい帯血及びさい帯の分離・保管を行う「細胞バ ンク事業」
保有者 | 2021.3 | 2021.9 | 2022.3 | 2023.3 | 2023.9 | 2024.3 | 2024.9 |
---|---|---|---|---|---|---|---|
(株)トリムメディカルホールディングス | 4,356,100 (89.5%) | 3,717,800 (72.57%) | 3,692,100 (72.06%) | 7,384,200 (72.06%) | 7,384,200 (72.06%) | 7,384,200 (72.06%) | 7,384,200 (72.07%) |
株式会社日本カストディ銀行 (信託口) | 145,800 (2.85%) | 170,000 (3.32%) | 324,000 (3.16%) | 325,100 (3.17%) | 339,100 (3.3%) | 355,500 (3.47%) | |
日本マスタートラスト信託銀行株式会社(信託口) | 85,600 (1.67%) | 79,200 (1.55%) | 266,200 (2.59%) | 333,000 (3.25%) | 289,300 (2.82%) | 299,300 (2.92%) | |
名古屋中小企業投資育成(株) | 84,000 (1.73%) | 84,000 (1.64%) | 84,000 (1.64%) | 168,000 (1.63%) | 168,000 (1.64%) | 168,000 (1.63%) | 168,000 (1.64%) |
野村信託銀行株式会社(投信口) | 51,300 (1.0%) | 67,800 (1.32%) | 161,200 (1.57%) | 148,000 (1.44%) | 151,000 (1.47%) | ||
山本 邦松 | 86,100 (1.77%) | 45,100 (0.88%) | 45,100 (0.88%) | 90,200 (0.88%) | 90,200 (0.88%) | 90,200 (0.88%) | 90,200 (0.88%) |
森 雅徳 | 62,300 (1.28%) | 62,300 (1.22%) | 62,300 (1.22%) | 124,600 (1.21%) | 84,600 (0.83%) | 84,600 (0.82%) | 84,600 (0.83%) |
Supercell Biotechnology Corporation(常任代理人 矢尾重雄) | 70,000 (0.68%) | 70,000 (0.68%) | 70,000 (0.68%) | ||||
ステムセル研究所従業員持株会 | 26,651 (0.52%) | 60,531 (0.59%) | |||||
若松 茂美 | 51,800 (1.06%) | 51,800 (0.51%) | |||||
BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC)(常任代理人 株式会社三菱UFJ銀行) | 82,400 (1.61%) | 107,300 (2.09%) | 339,400 (3.31%) | 273,900 (2.67%) | 177,400 (1.73%) | ||
野村證券株式会社 | 126,400 (1.23%) | 94,916 (0.93%) | 100,741 (0.98%) | ||||
野村信託銀行株式会社(投信口)) | 142,000 (1.38%) | ||||||
Sino Cell Technologies Inc. | 70,000 (0.68%) | ||||||
SINO CELL TECHNOLOGIES INC.(常任代理人 芳賀 敦子) | 35,000 (0.72%) | 35,000 (0.68%) | 35,000 (0.68%) | ||||
日本証券金融株式会社 | 35,600 (0.69%) | ||||||
友清 彰 | 25,200 (0.52%) | ||||||
浅井 芳明 | 24,500 (0.5%) | ||||||
野上 大介 | 14,000 (0.29%) | ||||||
森崎 弘司 | 14,000 (0.29%) | ||||||
浦野 晃義 | 14,000 (0.29%) |